Questioning Medicine
Questioning Medicine
Join Andrew on a medical rollercoaster as we ask a medical question and answer it based on recent published papers.
No dejes de visitar la web del podcast y apoyar a su creador: www.podomatic.com
Autor
Questioning Medicine
Categoría
Web del podcast
Último episodio
21 de oct. de 2026
¿Dónde escuchar?
Podcasts en la app Replaio Radio Muy prontoLos podcasts llegarán muy pronto a la app. Instálala ahora y sé el primero en descubrir una forma totalmente nueva de vivir los podcasts
Episodios
Episode 414: 421. Scabies and DUKE criteria 25.02.2026 11:42
Stavropoulou E, et al. Reassessing the 2023 International Society for Cardiovascular Infectious Diseases Duke clinical criteria for infective endocarditis: Impact of excluding fever and updating diagnostic definitions. Clin Infect Dis 2025 Dec 31; [e-pub]. DOI: 10.1093/cid/ciaf737 . Big takeaways About 35% of patients truly had IE. Fever showed up in 80% of patients both with and without IE, so...
Episode 413: 420. Frail and CODE LVO PLUS antibiotics don't help viral illness 05.02.2026 19:37
we look at CODE LVO and what does being frail even mean????? vaccines may not help baby and antibiotics still don't help viral illness
Episode 412: CME song --Check the Lytes 20.01.2026 3:09
CME song --Check the Lytes
Episode 411: CME - sodium, potassium, calcium 20.01.2026 43:02
CME - sodium, potassium, calcium
Episode 410: 418. Beta Blockers Post MI, PSA, Youtube, 15.12.2025 40:49
10.1016/j.jaip.2025.07.005 .40675327 All of the videos were found to be useful or very useful, 99% were of moderate or high reliability, and 99% had moderate to excellent educational quality Prostate-specific antigen levels among participants receiving annual testing. JAMA Oncol 2025 Nov; 11:1341 10.1001/jamaoncol.2025.3386 .40965920 PSA levels at or above 4.0 ng/mL fell below that threshold o...
Episode 409: 417. Aspirin, Pre-diabetes, Menopause, Type 1 Diabetes, HPV Vaccine and more!!!! 03.12.2025 34:04
Wolfe R, Broder JC, Zhou Z, et al. Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trial. Eur Heart J. 12 Aug 2025. [Epub ahead of print]. https://pubmed.ncbi.nlm.nih.gov/40796244/ Donocan LE et al. Closed-loop insulin delivery in type 1 diabetes in pregnancy: The CIRCUIT randomized clinical trial. JAMA 2025 Oct 24; [e-pub]. ( https://doi.org/...
Episode 408: 416. Car Seats, Beta-Blockers after a Heart Attack, Oral Semaglutide, High-Dose influenza vaccine 17.11.2025 22:55
Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction - https://www.nejm.org/doi/full/10.1056/NEJMoa2504735?query=WB McGuire DK et al. Oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes. N Engl J Med 2025 Mar 29; [e-pub]. ( https://doi.org/10.1056/NEJMoa2501006 ) Interactive Virtual Presence to Remotely Assist Parents With Car Seat Installation ht...
Episode 407: 415. Do Air Filters Lower Blood Pressure? 12.11.2025 9:34
https://pubmed.ncbi.nlm.nih.gov/40767818/ This is a great example for students and residents to look and see that the abstract does not always match what the paper actually says
Episode 406: 414. Resistant Hypertension, Physical Therapy, Steroids for Pneumonia 03.11.2025 15:46
Efficacy and safety of Baxdrostat in uncontrolled and resistant hypertension compared to placebo in phase three when there are MRA available that are cheap and available A randomised trial of physical therapy for meniscal tear and knee pain discovers that home exercises are just as good as inperson physical therapy a Pragmatic trial of glucocorticoids for community acquired pneumonia that I don't...
Episode 405: 413. 4 Articles to Scare You-- COPD, Cirrhosis, ETOH, and Ablation 31.10.2025 18:34
gabapentin may increase COPD exacerbations Benzo for ETOH might be long gone..guess what is going to replace it Anticoagulation after ablation.... what do you do with it? BBlocker in those with cirrhosis and varices
Episode 404: 412. Liver Transplant - The One Referral I Doubt You Are Doing Correctly 24.10.2025 7:25
Clinicians should refer patients for liver transplant evaluation after any decompensation event —such as ascites or variceal bleeding— regardless of MELD score . After a first decompensation, 5-year mortality is 20–30% ; after a second, it rises to 80–90% . Refractory ascites carries a 50% 1-year mortality , and overt hepatic encephalopathy has a 25–40% 1-year mortality . After an initial variceal...
Episode 403: 411. Gabapentin and Emergency Carotid Artery Stenting in Stroke 22.10.2025 10:08
Study Summary: Emergent Carotid Stenting in Acute Stroke Thrombectomy A multicenter registry study in Catalonia (2017–2023) evaluated outcomes in 578 patients with acute ischemic stroke and tandem lesions (large-vessel occlusion plus extracranial carotid stenosis). Patients were divided into two groups: those who received emergent carotid artery stenting (E-CAS) and those who did not ( non-CAS )....
Episode 402: 410. When You Shouldn't Double Down But Instead Hit for Another 16.10.2025 8:18
This massive meta-analysis of 484 randomized, double-blind, placebo-controlled trials (104,176 participants) quantified the blood pressure–lowering effects of major antihypertensive drug classes and their combinations. It introduces a new intensity-based classification system and an online calculator to predict BP-lowering efficacy based on drug, dose, and baseline BP. Study Design: 484 trials, 10...
Episode 401: 409. The Effects of Upper Extremity and Lower Extremity Aerobic Exercise Training in Patients with Peripheral Arterial Disease: 14.10.2025 7:12
Practice Pearls: “Skip Leg Day” (Sometimes) For PAD patients who can’t tolerate leg workouts, upper body aerobic training is a strong, evidence-backed alternative . It’s not just a workaround—it’s a workout. Citation Ahiskali GN, Demirel A, Yamikan H, Kutukcu EC. The Effects of Upper Extremity and Lower Extremity Aerobic Exercise Training in Patients with Peripheral Arterial Disease: A Systematic...
Episode 400: 408. CME Obesity and MASH 27.09.2025 1:02:42
GLP1 drugs work but they likely need lifestyle modifications No convincing evidence GLP1 cause thyroid cancer in humans BUT contraindication if family history exist Stopping therapy usually results in weight gain Insurance coverage for weight loss is limited and variable Semaglutide for type 2 diabetes max dose is 2.0 mg weekly Semaglutide for weight loss has a goal dose of 2.4 mg weekly Diagnose...
Episode 399: 407. OMED COPD CME 22.09.2025 39:38
OMED COPD CME
Episode 398: 406. Update of Medical Articles 27.08.2025 29:58
All of these articles have been talked about on questioning medicine social media on tik tok and instagram but here is an update of my recent reading
Episode 397: 405. 4 New Medical Articles That Are Deceiving 01.08.2025 19:00
Buelt, Andrew | 2:13 PM (1 hour ago) | | to me https://jamanetwork.com/journals/jama/fullarticle/2833338 Conclusions and Relevance These results support use of metformin for treatment of symptomatic knee osteoarthritis in people with overweight or obesity. Because of the modest sample size, confirmation in a larger clinical trial is warranted. Lee S et al. Live zoster vaccination and...
Episode 396: 404. albuterol/budesonide, DOAC in 4 Days, Statins for AAA 24.07.2025 12:03
https://www.nejm.org/doi/10.1056/NEJMoa2504544 During follow-up ranging from 12 to 52 weeks, fewer patients had severe exacerbations in the albuterol/budesonide group than in the albuterol group (5% vs. 9%). Patients in the albuterol/budesonide group had less than half the total exposure to systemic glucocorticoids as those in the albuterol group (mean, 23 vs. 62 mg per year). Clinical Pra...
Episode 395: 403. COVID Maternal Booster And Cervical Self Swabs 22.07.2025 10:28
https://publications.aap.org/pediatrics/article/156/1/e2024070175/202234/Infant-Antibodies-After-Maternal-COVID-19?autologincheck=redirected Objective: The study aimed to evaluate the kinetics and duration of maternally derived antibodies in infants up to 6 months old, following maternal COVID-19 vaccination during pregnancy or postpartum. Study Design: A prospective multicenter cohort study was...
Episode 394: 402. Cardiovascular Risk Factors, Zilebesiran, Shared Decision Making 18.07.2025 15:05
https://www.nejm.org/doi/10.1056/NEJMoa2415879?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed Key Findings: Classic Risk Factors: The five risk factors examined were hypertension, hyperlipidemia, underweight and overweight or obesity, diabetes, and smoking. These factors are estimated to account for about 50% of the global burden of cardiovascular disease. Li...
Episode 393: 404. 3 quick articles you might want to know about (oral semaglutide, tiktok, and GLP1 thyroid cancer) 25.06.2025 12:30
GLP1 might cause thyroid cancer in mice but the evidence is drastically lacking in humans Oral semaglutide is expensive for an NNT of 50 at 4 yrs Tiktok videos of skin care are a scam
Episode 392: 403. 3 Papers, 1 Podcast - One Guideline Changer 16.06.2025 14:11
https://jamanetwork.com/journals/jama/article-abstract/2834040 amiloride is realistically equal to spironolactone for resistant HTN https://journals.lww.com/ajg/abstract/2025/05000/higher_rate_of_spontaneous_bacterial_peritonitis.24.aspx prophalaxis antibiotics might not be needed https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2834317 If you got a friend in weight loss-- or...
Episode 391: 402. Functional disability after clinically significant extracranial bleeding: a secondary analysis of ASPREE 05.06.2025 7:45
https://www.jthjournal.org/article/S1538-7836(25)00109-6/fulltext Antithrombotic agents, like aspirin and anticoagulants, are essential for treating many cardiovascular conditions. However, a common side effect is bleeding, with extracranial bleeding—bleeding outside the brain and spinal cord—being quite prevalent. This study, a secondary analysis of the Aspirin in Reducing Events in the Elderly,...
Episode 390: 401. Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension 04.06.2025 8:46
https://jamanetwork.com/journals/jama/article-abstract/2834632 Summary The article examines the effectiveness and safety of zilebesiran, an RNA interference therapeutic agent, when used in combination with standard first-line antihypertensive drugs for patients with inadequately controlled hypertension. The phase 2, prospective, randomized, double-blinded trial was conducted over multiple internat...
Podcasts similares
Replaio no es editor de podcasts; los nombres de los programas, las portadas y el audio pertenecen a sus autores y se distribuyen a través de canales RSS públicos